Skip to main content
Erschienen in: Abdominal Radiology 8/2016

10.03.2016

Comparison of Doppler ultrasound and transient elastography in the diagnosis of significant fibrosis in patients with nonalcoholic steatohepatitis

verfasst von: Rabia Ergelen, Yusuf Yilmaz, Ruslan Asedov, Cigdem Celikel, Hakan Akin, Onur Bugdayci, Ersan Altun, Davut Tuney

Erschienen in: Abdominal Radiology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Liver fibrosis is an important prognostic determinant in patients with nonalcoholic steatohepatitis (NASH). Hepatic artery resistivity index (HARI) is a doppler ultrasonography (US) parameter that is used to follow up microcirculatory resistance in fatty liver. We aimed to asses whether it is possible to demonstrate significant fibrosis by means of doppler US in comparison with transient elastography (TE) and liver biopsy in NASH patients.

Patients and methods

A total of 63 (mean age 47.1 ± 8.4 years, 39 male, 24 female) biopsy-proven NASH patients were enrolled in this prospective study. The study population was classified into two groups: significant and no-significant fibrosis patients. Doppler US and TE were performed in two groups.

Results

HARI and TE values were significantly higher in significant fibrosis group (0.81 ± 0.05 vs. 0.63 ± 0.14, p < 0.0005; 15.9 ± 4.8 vs. 6.2 ± 2.6 kilopascals, p < 0.0005; respectively). Based on the ROC curve, the optimal cut-off value of HARI for a significant fibrosis was >0.75, which yielded a sensitivity of 78% and a specificity of 75%, with the area under the curve at 0.90. The optimal cut-off value of TE for a significant fibrosis was >9.8 kilopascals, which yielded a sensitivity of 90% and a specificity of 91%, with the area under the curve at 0.95. HARI values were moderately correlated with TE values (r = 0.53, p < 0.001).

Conclusion

Doppler US has moderate % sensitivity and % specificity, which is lower compared with TE for the diagnosis significant fibrosis. However, it may be used as an alternative method for the assessment of fibrosis in patients with NASH who are not good candidates for TE evaluation.
Literatur
1.
Zurück zum Zitat Bellentani S, Saccoccio G, Masutti F, et al. (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132(2):112–117CrossRefPubMed Bellentani S, Saccoccio G, Masutti F, et al. (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132(2):112–117CrossRefPubMed
2.
Zurück zum Zitat Marchesini G, Bugianesi E, Forlani G, et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37(4):917–923CrossRefPubMed Marchesini G, Bugianesi E, Forlani G, et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37(4):917–923CrossRefPubMed
3.
Zurück zum Zitat Bugianesi E, Leone N, Vanni E, et al. (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123(1):134–140CrossRefPubMed Bugianesi E, Leone N, Vanni E, et al. (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123(1):134–140CrossRefPubMed
5.
Zurück zum Zitat Obika M, Noguchi H (2012) Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012:1–12CrossRef Obika M, Noguchi H (2012) Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012:1–12CrossRef
6.
Zurück zum Zitat Polyzos SA, Mantzoros CS (2014) Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63(2):161–167CrossRefPubMed Polyzos SA, Mantzoros CS (2014) Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63(2):161–167CrossRefPubMed
7.
Zurück zum Zitat Merriman RB, Ferrell LD, Patti MG, et al. (2006) Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44(4):874–880CrossRefPubMed Merriman RB, Ferrell LD, Patti MG, et al. (2006) Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44(4):874–880CrossRefPubMed
8.
Zurück zum Zitat Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99(6):1160–1174CrossRefPubMed Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99(6):1160–1174CrossRefPubMed
9.
10.
Zurück zum Zitat Castéra L, Vergniol J, Foucher J, et al. (2005) Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128(2):343–350CrossRefPubMed Castéra L, Vergniol J, Foucher J, et al. (2005) Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128(2):343–350CrossRefPubMed
11.
Zurück zum Zitat Verveer C, Zondervan PE, ten Kate FJ, et al. (2012) Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int 32(4):622–628CrossRefPubMed Verveer C, Zondervan PE, ten Kate FJ, et al. (2012) Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int 32(4):622–628CrossRefPubMed
12.
Zurück zum Zitat Myers RP, Pomier-Layrargues G, Kirsch R, et al. (2012) Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 56(3):564–570CrossRefPubMed Myers RP, Pomier-Layrargues G, Kirsch R, et al. (2012) Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 56(3):564–570CrossRefPubMed
13.
Zurück zum Zitat Harata M, Hashimoto S, Kawabe N, et al. (2011) Liver stiffness in extrahepatic cholestasis correlates positively with bilirubin and negatively with alanine aminotransferase. Hepatol Res 41(5):423–429CrossRefPubMed Harata M, Hashimoto S, Kawabe N, et al. (2011) Liver stiffness in extrahepatic cholestasis correlates positively with bilirubin and negatively with alanine aminotransferase. Hepatol Res 41(5):423–429CrossRefPubMed
14.
Zurück zum Zitat Gaia S, Carenzi S, Barilli AL, et al. (2011) Reliability of transient elastography for the detection of fibrosis in nonalcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 54:64–71CrossRefPubMed Gaia S, Carenzi S, Barilli AL, et al. (2011) Reliability of transient elastography for the detection of fibrosis in nonalcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 54:64–71CrossRefPubMed
15.
Zurück zum Zitat Yoneda M, Yoneda M, Fujita K, et al. (2007) Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 56:1330–1331CrossRefPubMedPubMedCentral Yoneda M, Yoneda M, Fujita K, et al. (2007) Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 56:1330–1331CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Wong VW, Vergniol J, Wong GL, et al. (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454–462CrossRefPubMed Wong VW, Vergniol J, Wong GL, et al. (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454–462CrossRefPubMed
17.
Zurück zum Zitat Pierce ME, Sewell R (1990) Identification of hepatic cirrhosis by duplex doppler ultrasound value of the hepatic artery resistive index. Australas Radiol 34(4):331–333CrossRefPubMed Pierce ME, Sewell R (1990) Identification of hepatic cirrhosis by duplex doppler ultrasound value of the hepatic artery resistive index. Australas Radiol 34(4):331–333CrossRefPubMed
18.
Zurück zum Zitat Tanaka K, Numata K, Morimoto M, et al. (2004) Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound. Dig Dis Sci 49(5):833–842CrossRefPubMed Tanaka K, Numata K, Morimoto M, et al. (2004) Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound. Dig Dis Sci 49(5):833–842CrossRefPubMed
19.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313–1321CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313–1321CrossRefPubMed
20.
Zurück zum Zitat Menghini G, Lauro G, Caraceni M (1975) Some innovations in the technic of the one-second needle biopsy of the liver. Am J Gastroenterol 64(3):175–180PubMed Menghini G, Lauro G, Caraceni M (1975) Some innovations in the technic of the one-second needle biopsy of the liver. Am J Gastroenterol 64(3):175–180PubMed
21.
Zurück zum Zitat Friedrich-Rust M, Rosenberg W, Parkes J, et al. (2010) Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 10:103CrossRefPubMedPubMedCentral Friedrich-Rust M, Rosenberg W, Parkes J, et al. (2010) Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 10:103CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Dincses E, Yilmaz Y (2015) Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2015:1149–1153CrossRef Dincses E, Yilmaz Y (2015) Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2015:1149–1153CrossRef
23.
Zurück zum Zitat Kim BK, Fung J, Yuen MF, et al. (2013) Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 19(12):1890–1900CrossRefPubMedPubMedCentral Kim BK, Fung J, Yuen MF, et al. (2013) Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 19(12):1890–1900CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kim SU, Kim BK, Han KH (2013) Clinical application of liver stiffness measurement using transient elastography: a surgical perspective. Digestion 88(4):258–265CrossRefPubMed Kim SU, Kim BK, Han KH (2013) Clinical application of liver stiffness measurement using transient elastography: a surgical perspective. Digestion 88(4):258–265CrossRefPubMed
25.
Zurück zum Zitat Zeng X, Xu C, He D, Zhang H, et al. (2015) Influence of hepatic inflammation on FibroScan findings in diagnosing fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol 41(6):1538–1544CrossRefPubMed Zeng X, Xu C, He D, Zhang H, et al. (2015) Influence of hepatic inflammation on FibroScan findings in diagnosing fibrosis in patients with chronic hepatitis B. Ultrasound Med Biol 41(6):1538–1544CrossRefPubMed
26.
Zurück zum Zitat Piscaglia F, Gaiani S, Calderoni D, et al. (2001) Influence of liver fibrosis on hepatic artery Doppler resistance index in chronic hepatitis of viral origin. Scand J Gastroenterol 36(6):647–652CrossRefPubMed Piscaglia F, Gaiani S, Calderoni D, et al. (2001) Influence of liver fibrosis on hepatic artery Doppler resistance index in chronic hepatitis of viral origin. Scand J Gastroenterol 36(6):647–652CrossRefPubMed
27.
Zurück zum Zitat Lim AK, Patel N, Eckersley RJ, et al. (2005) Can Doppler sonography grade the severity of hepatitis C-related liver disease? AJR Am J Roentgenol 184(6):1848–1853CrossRefPubMed Lim AK, Patel N, Eckersley RJ, et al. (2005) Can Doppler sonography grade the severity of hepatitis C-related liver disease? AJR Am J Roentgenol 184(6):1848–1853CrossRefPubMed
28.
Zurück zum Zitat Lutz HH, Schroeter B, Kroy DC, et al. (2015) Doppler ultrasound and transient elastography in liver transplant patients for noninvasive evaluation of liver fibrosis in comparison with histology: a prospective observational study. Dig Dis Sci 60(9):2825–2831CrossRefPubMed Lutz HH, Schroeter B, Kroy DC, et al. (2015) Doppler ultrasound and transient elastography in liver transplant patients for noninvasive evaluation of liver fibrosis in comparison with histology: a prospective observational study. Dig Dis Sci 60(9):2825–2831CrossRefPubMed
29.
Zurück zum Zitat Sudhamshu KC, Sharma D, Chataut SP (2010) Hepatic vein waveforms in liver cirrhosis re-evaluated. Hepatol Int 5(1):581–585 Sudhamshu KC, Sharma D, Chataut SP (2010) Hepatic vein waveforms in liver cirrhosis re-evaluated. Hepatol Int 5(1):581–585
30.
Zurück zum Zitat Oguzkurt L, Yildirim T, Torun D, et al. (2005) Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 54(2):253–257CrossRefPubMed Oguzkurt L, Yildirim T, Torun D, et al. (2005) Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 54(2):253–257CrossRefPubMed
Metadaten
Titel
Comparison of Doppler ultrasound and transient elastography in the diagnosis of significant fibrosis in patients with nonalcoholic steatohepatitis
verfasst von
Rabia Ergelen
Yusuf Yilmaz
Ruslan Asedov
Cigdem Celikel
Hakan Akin
Onur Bugdayci
Ersan Altun
Davut Tuney
Publikationsdatum
10.03.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 8/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0699-6

Weitere Artikel der Ausgabe 8/2016

Abdominal Radiology 8/2016 Zur Ausgabe

Classics in Abdominal Imaging

The “manta ray” pelvis

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.